Aims: In a search for an antifungal peptide with a high activity against Aspergillus¯avus, Bacillus subtilis AU195 was selected from a collection of isolates with antagonistic activity against A.¯avus. Methods and Results: To identify the antifungal peptides, a protein puri®cation scheme was developed based on the detection of the antifungal activity in puri®ed fractions against A.¯avus. Two lipopeptides were puri®ed with anion exchange and gel ®ltration chromatography. Their masses were determined to be 1045 and 1059 1 m/z with mass spectrometry, and their peptide moiety was identical to bacillomycin D. Conclusions: AU195 synthesized a mixture of two antifungal bacillomycin D analogues with masses of 1045 and 1059, the 14 mass unit difference representing the difference between a C15 and a C16 lipid chain. Signi®cance and Impact of the Study: Both bacillomycin D analogues were active at the same concentration against A.¯avus, but the different lipid chain length apparently affected the activity of the lipopeptide against other fungi.
INTRODUCTION
A¯atoxins are extremely toxic chemicals which can cause liver cancer in animals and humans when contaminated feed or food is consumed. A¯atoxin production occurs when Aspergillus¯avus or A. parasiticus invades peanuts, cotton seed, corn and certain nuts under favourable conditions of temperature and humidity. Aspergillus spp. 2 are also involved in respiratory infection in immunode®cient patients (Lotholary et al. 1993) . Currently available control methods, such as use of optimal cultural practices, have reduced but have not eliminated pre-harvest a¯atoxin contamination in susceptible crops. Identi®cation of new antifungal peptides with activity against A.¯avus could lead to the development of biotechnological strategies for controlling a¯atoxin contamination and, for example, increase plant resistance to fungal invasion through genetic engineering. During the screening of bacteria for antagonistic activity against A.¯avus in vitro, a Bacillus subtilis isolate, AU195, was identi®ed as having the highest antifungal activity.
The potential of Bacillus spp. 3 to synthesize a wide variety of metabolites with antibacterial and/or antifungal activity has been intensively exploited in medicine and industry, and is one determinant of their ability to control plant diseases when applied as a biological control agent (McKeen et al. 1986; Silo-suh et al. 1994; Leifert et al. 1995) . Most of the antifungal peptides secreted by B. subtilis have a molecular weight of less than 2000 Da and are synthesized nonribosomally via a multi-enzyme-catalysed synthesis (Zuber et al. 1993) . The antibiotics synthesized non-ribosomally include the lipopeptides iturin (Maget-Dana and Peypoux 1994) , surfactin (Kluge et al. 1988) , fengycin (Vanittanakom et al. 1986) , plipastatin (Tsuge et al. 1996) , the di-and tripeptides such as bacilysin (Walker and Abraham 1970) , and the phosphono-oligopeptide, rhizocticin (Kugler et al. 1990) . Iturin is a group of cyclic lipopeptides with a peptide moiety and a b-amino fatty acid linked by amide bonds to the constituent amino acid residues. They share a common sequence (b-hydroxy fatty acid-Asx-Tyr-Asx) and show variation at the other four positions (Maget-Dana and Peypoux 1994) . Iturin A, C, D and E (Besson et al. 1978a; Besson and Michel 1987) , bacillomycin D (Peypoux et al. 1984) , F (Mhammedi et al. 1982) and L (Peypoux et al. 1984) , bacillopeptin (Kajimura et al. 1995) and mycosubtilin (Peypoux et al. 1986) belong to the iturin group. Surfactin is also a cyclic lipopeptide, containing seven residues of D D-and L L-amino acids and one residue of a b-hydroxy fatty acid (Kluge et al. 1988) , with an amino acid sequence completely different from the iturin group. Fengycin (Vanittanakom et al. 1986 ) and plipastatin (Tsuge et al. 1996) are lipopeptides with 10 amino acids and a lipid attached to the N-terminal end of the molecule. They differ from iturin and surfactin by the presence of unusual amino acids such as ornithine and allo-threonine. The purpose of this study was to isolate, purify and characterize the antifungal substance(s) produced by B. subtilis AU195 from the culture ®ltrate, and to assess the antifungal spectrum of the puri®ed antifungal compound(s).
MATERIALS AND METHODS

Micro-organisms
Bacillus subtilis AU195 was selected from a bacterial collection of Auburn University for its ability to inhibit A.¯avus in vitro. The strain AU 195 was identi®ed as close to B. subtilis upon determination of fatty acid methyl ester pro®les by gas chromatography (Sasser 1990 ). An A.¯avus strain was isolated and identi®ed from an Alabama peanut kernel. Alternaria solani, Fusarium oxysporum, Botryosphaeria ribis, Helminthosporium maydis, Phomopsis gossypii, Colletotrichum gloeosporioides and Sclerotium rolfsii were provided by the Plant Diagnostic Lab (Auburn University).
Culture conditions
A single bacterial colony was inoculated into 1 ml LuriaBertani (LB) medium and cultured overnight at 27°C with constant shaking at 140 rev min ±1 (Orbit shaker, Lab-line 4 , Melrose Park, IL, USA). For the production of the antifungal compounds, 2 l¯asks each containing 1 l LB medium were inoculated with this overnight culture and incubated at 27°C with constant shaking at 80 rev min ±1 . Every day, samples (5 ml) were removed and centrifuged (10 000 g for 10 min). The supernatant¯uids were ®lter-sterilized (0á22 lm Acrodisc HT Tuffryn membrane, Gelman Sciences 5 , Ann Arbor, MI, USA) and tested for antifungal activity.
Antifungal assay
Microtitre plate assay. Culture supernatant¯uids were tested for their antifungal activity against A.¯avus in a microtitre plate (Falcon 3918, , Franklin Lakes, NJ, USA). Each well contained 100 ll Potato Dextrose broth (PDB, Difco) and 100 ll culture ®ltrate, and each was inoculated with 500 spores of A.¯avus. In the control well, culture ®ltrate was replaced by LB medium. Fungal growth was monitored by reading optical density (O.D.) at 560 nm (Dynatech microplate reader 7 , Chantilly, VA, USA).
Disc plate diffusion assay. Mycelial plugs from the edges of actively-growing fungal cultures were placed in the centre of the Petri plate, containing LB medium supplemented with 15 g l ±1 agar for A.¯avus and PDA for A. solani, F. oxysporum, B. ribis, H. maydis, P. gossypii, C. gloeosporioides and S. rolfsii. After incubation at 27°C to allow vegetative growth, samples were applied to sterile ®lter paper discs laid on the agar surface at a distance of 5 mm from the edge of the colony. The antifungal activity of each fraction at the different puri®cation steps was evaluated against A.¯avus. The puri®ed peptides analogues were tested against A. solani, F. oxysporum, B. ribis, H. maydis, P. gossypii, C. gloeosporioides and S. rolfsii. The results were observed after 24 h and the antifungal activity was evaluated by the presence of an inhibition zone.
Iturin A (I-1774) was purchased from Sigma and was composed of C14 and C15 b-amino acids.
Protein determination
Protein concentration was measured by the method of Bradford (Bradford 1976 ) using Bio-Rad reagents and bovine serum albumin as a standard.
Puri®cation of the active compound
Step 1. Ammonium sulphate fractionation. After 7 days, the culture was centrifuged (Sorvall RC5C centrifuge with a GSA rotor, 10 000 g, 30 min at 4°C) to remove the bacteria. The culture supernatant¯uid was subjected to sequential ammonium sulphate precipitation to achieve 20, 40, 60 and 80% saturation at 0°C with constant and gentle stirring. The precipitated proteins were pelleted by centrifugation at 10 000 g for 20 min. The protein pellet was dissolved in 0á02 mol l ±1 sodium phosphate buffer, pH 7á0, and dialysed using a 3500 MW cut-off membrane (Spectra/ por 3, Spectrum 8 , Houston, TX, USA), overnight, at 4°C, against the same buffer. The crude preparation was then stored at ±80°C for further analysis.
Step 2. Anion exchange chromatography. The crude preparation was loaded onto a 5 ml anion exchange column (HiTrap Q Pharmacia 9 , Piscataway, NJ, USA). The column was connected to an FPLC system (ConSep LC 100, PerSeptive Biosystems 10 , Fragmingham, MA, USA) and a linear gradient of 0±1á6 mol l ±1 NaCl, including 20 mmol l ±1 phosphate buffer, pH 7, was applied. Twenty fractions of 5 ml were collected and 50 ll per fraction were tested in the disc diffusion assay. All the fractions with antifungal activity were pooled, dialysed against water and freeze-dried.
Step 3. Gel ®ltration chromatography. Gel ®ltration chromatography was performed with a Superdex peptide PE 7á5/300 column (Pharmacia 11 ) for analytical analyses and a Superdex peptide HiLoad 16/60 column (Pharmacia) for preparative separation connected to an HPLC system (Waters 12 , Milford, MA, USA). The absorbance was monitored at 210 and 280 nm with a photodiode array (PDA, Waters). Proteins (100 lg) from step 2 were analysed on a Superdex peptide PE 7.5/300 column which was eluted with 20 mmol l ±1 phosphate buffer, pH 7á5, isocratically at ā ow rate of 0á5 ml min ±1 . All the peaks were collected as separate fractions, freeze-dried and tested for antifungal activity in a disc plate diffusion assay. To purify a suf®cient amount of the antifungal peptides, 33 mg of the freeze-dried material with antifungal activity was loaded on a preparative Superdex peptide HiLoad 16/60 column (Pharmacia) and eluted with 20 mmol l ±1 phosphate buffer, pH 7á5, isocratically at a¯ow rate of 1 ml min ±1 .
Detection of antifungal activity in SDS-PAGE gel electrophoresis
SDS PAGE was performed in a Mini-Protean II electrophoresis system (Bio-Rad) by the discontinuous method of Laemmli (Laemmli 1970) . Protein samples were prepared as described by Laemmli (Laemmli 1970) and boiled for 5 min. The crude 20% ammonium sulphate fraction (50 ll) was separated on 16% SDS-PAGE gel and the electrophoresis was stopped when the blue dye reached 1 cm from the end of the gel. A suspension of A.¯avus spores (5000 spores ml ±1 ) in melted and cooled PDA medium (50°C) was plated in a Petri dish and incubated for 4 h at 27°C. After electrophoresis, a 16% SDS-PAGE gel was overlaid for 1 min on the PDA plate containing A.¯avus spores and removed for further silver staining. The PDA plate was incubated at 37°C for 24 h until the inhibition zone was visible.
Isoelectric Focusing (IEF) 13 electrophoresis Acrylamide (7%) tube gels containing 2% ampholite (BioRad), pH range 2±8, and 10% glycerol were cast in a Hoefer GT1 unit (Amersham Pharmacia Biotech 14 ). Electrophoresis was carried on overnight at 400 V, 4°C, with 0á02 mol l ±1 sodium hydroxide for the cathode solution and 10% phosphoric acid for the anode solution. A 50 ll (50 lg) aliquot of the 20% ammonium sulphate-precipitated proteins, mixed with 10% (v/v) glycerol, was loaded per tube gel. Afterwards, electrophoresis gels were cut into 1 cm pieces. The pH of each gel fraction (total of 15) was determined and the fractions were placed on LB agar media pre-inoculated with A.¯avus.
Mass spectrometry and sequencing
Mass spectrometry and peptide sequencing were performed by the Protein Chemistry Core Facility at Baylor College of Medicine, One Baylor Plaza, Houston, Texas 77030±3498, USA.
RESULTS
Production of the antifungal substances
Bacillus subtilis strain AU 195 inhibited the growth of A.¯avus on a PDA plate as indicated by the inhibition zone. The active substance was secreted in the culture ®ltrate when AU 195 was cultured in LB medium, and the production was monitored during 7 days with a microtitre plate assay. Aspergillus¯avus growth, measured by O.D. at 560 nm, was inhibited by the ®ltrate collected 2, 3, 4, 5, 6 and 7 days after starting the bacterial culture (Fig. 1) . The antifungal substance production increased every day to reach a maximum at 6 days. Culture ®ltrate collected at 6 and 7 days completely inhibited fungal spore germination and hyphal growth (Fig. 1) .
Partial puri®cation of the antifungal substance
All protein fractions and supernatant¯uids precipitated sequentially with 20, 40, 60 and 80% ammonium sulphate were tested before and after dialysis with a disc plate diffusion assay. Ammonium sulphate salt did not inhibit A.¯avus at the concentration used and did not modify the result of the assay. The antifungal activity against A.¯avus was present mainly in the fraction precipitated with 20% ammonium sulphate. Fractions precipitated with 40 and 60% ammonium sulphate exhibited a weak inhibition. Supernatant¯uid and 80% ammonium sulphate precipitate did not exhibit any antifungal activity. The antifungal substance present in the 20% fraction inhibited both hyphal growth and spore germination. Even after one month, spores had not germinated in the presence of the 20% ammonium sulphate fraction.
Characterization of the antifungal substances
To determine the pI of the antifungal protein, proteins in the 20% ammonium sulphate fraction were separated by IEF. Upon IEF and bioassay of gel sections, the active proteins were demonstrated to have an isoelectric point of 4á5, indicating that the antifungal substances have an acidic isoelectric point.
When the 20% ammonium sulphate protein fraction was separated on a 16% acrylamide gel, the antifungal activity remained in a single band co-migrating with the bromophenol blue front (Fig. 2) , indicating a low molecular weight for the antifungal protein (less than 6 kDa). The antifungal substance was able to diffuse very rapidly into the gel; 1 min overlaid was enough to obtain an inhibition zone. Boiling the samples prior to electrophoresis did not destroy the antifungal activity and it was therefore concluded that the antifungal substance was heat stable.
Puri®cation of the antifungal peptides by anion exchange and gel ®ltration
Because of its acidic pI, the antifungal peptides were further puri®ed with an anion exchange chromatography column. All the antifungal activity was contained in fractions eluting with 0á5±1 mol l ±1 sodium chloride. Antifungal fractions A suspension of Aspergillus¯avus spores (5000 spores ml ±1 ) in PDB medium was plated in a Petri dish and incubated for 4 h at 27°C. After electrophoresis, the 16% SDS PAGE gel was overlaid on the PDA plate containing A.¯avus spores for 1 min and removed for further silver-staining. The antifungal inhibition zone was observed 24 h after incubating the PDA plate containing A.¯avus at 37°C Time (min) Fig. 3 Gel ®ltration chromatogram of 100 lg of protein from the partially-puri®ed fraction after anion exchange chromatography separation. Fractions were analysed on a Superdex peptide PE 7á5/300 column connected to an HPLC system. The column was eluted with 20 mmol l ±1 phosphate buffer, pH 7á5, isocratically at a¯ow rate of 0á5 ml min ±1 . All peaks were collected as separate fractions and tested for antifungal activity using a disc plate diffusion assay were pooled and 100 lg of proteins were analysed on a Superdex peptide PE 7á5/300 (Pharmacia) (Fig. 3) . All the peaks were collected as separate fractions and only two peaks, eluting at 27 and 38 min, had antifungal activity (Fig. 3.) . The elution times of both peptides corresponded to a molecular weight lower than the glycine (MW 75), which was used as a standard, due to interactions between the column media and the peptides. Thus, it was not possible to determine the molecular weight of the antifungal peptides by gel ®ltration. Complete puri®cation of both peptides was achieved by preparative gel ®ltration using a Superdex peptide HiLoad 16/60 column (Pharmacia) (Figs 4, 6 a, b) . Both antifungal fractions were de-salted on a C18 reverse phase HPLC column (Delta Pack C18 Waters) and the two peptides were eluted with a linear gradient of acetonitrile 5±60% containing 0á1% tri¯uoro-acetic acid (TFA) 15
. Single band homogeneity was demonstrated for the peptides by SDS gel electrophoresis (Fig. 5) . The molecular mass was determined by mass spectroscopy (Fig. 6c, d ). The molecular weight of the antifungal peptides was estimated to be 3á5 kDa with a 16% SDS gel and, respectively, 1045 for a1 and 1059 for a2 with mass spectrometry.
Amino acid sequence of a1 and a2
Initial Edman sequencing was unsuccessful. Tandem mass spectrometry of the molecular ion resulted in a highly complex spectrum which suggested a cyclic structure for both peptides. Peptide a1 was digested to give a linear molecule and the sequence after digestion at the Glu-C amino acid was NH2-STNYNPE-OH. A modi®cation of the molecule at the Thr residue suggested the attachment of hydroxy fatty acid. Peptide a1 has the same amino acid sequence and mass as reported for the bacillomycin D (Peypoux et al. 1984) .
Tandem mass spectrometry of the cyclic form of a2 indicated a sequence similar to a1 with an additional CH2. Peptide a2 has an amino acid sequence identical to bacillomycin D, but its mass is higher (m/z 1059) than the one published by Peypoux et al. (1984) (m/z 1031 and 1045).
Antifungal activity of the puri®ed bacillomycin D
The amount of bacillomycin D was estimated by the weight of the dry, puri®ed and de-salted fraction, as the Bradford assay was not accurate 16 to evaluate the concentration of small peptides. The antifungal spectra of bacillomycin D analogues a1 and a2 are shown in Table 1 . Most of the fungal strains tested are plant pathogens and were found to be highly sensitive to both antibiotics. Although A.¯avus hyphae are sensitive to the same concentration of a1 and a2, A. solani, C. gloeosporioides and S. rolfsii are differentially sensitive to a1 and a2. The lipid moiety of bacillomycin D plays a role in the differential antifungal properties observed when the fungi were screened. The antifungal activity of bacillomycin D was compared with iturin A against A.
avus; no inhibition zone was visible, even with 50 lg of iturin A.
DISCUSSION
In a search for an antifungal peptide with a high activity against A.¯avus, B. subtilis AU195 was selected from a Time (min) Fig. 4 Preparative chromatogram of the antifungal fraction after anion exchange chromatography separation. Fractions were separated on a Superdex peptide Hiload 16/60 column connected to an HPLC system. The column was eluted with 20 mmol l ±1 phosphate buffer, pH 7á5, isocratically at a¯ow rate of 1 ml min ±1 . All peaks were collected as separate fractions and tested for antifungal activity using a disc plate diffusion assay collection of isolates with antagonistic activity against A.¯avus. To purify the antifungal peptides, a protein puri®cation scheme was developed based on the detection of the antifungal activity in puri®ed fractions against A.¯avus. Two lipopeptides, puri®ed from B. subtilis AU195, were shown to be antifungal and have an amino acid sequence identical to bacillomycin D described by Peypoux et al. (1984) . Peypoux et al. (1984) reported that the FAB mass spectrum of bacillomycin D displayed two major peaks with a mass unit of 1031 and 1045. C14 and C15 b-amino acids were the major components of bacillomycin D, with a low percentage of C16 lipid components. AU195 synthesized a mixture of two antifungal bacillomycin D analogues with masses of 1045 and 1059, the 14 mass unit difference representing the difference between a C15 and a C16 lipid chain. Bacillomycin D exhibits a strong antifungal activity against A.¯avus and a broad range of plant pathogenic fungi. Iturin A, which belongs to the same iturin group as bacillomycin D, has been reported to inhibit a¯atoxin production by A.¯avus and A. parasiticus (Ono and Kimura 1991) . Although iturin A has already been patented for control of a¯atoxin, it was later described not to be able to inhibit A.¯avus growth and a¯atoxin production (Klich et al. 1994) . In the antifungal assay reported here, iturin A was not effective in controlling A.¯avus growth. Antibiotics of the iturin group were found to act upon the sterol present in the cytoplasmic membrane of the organism (Quentin et al. 1982) . Aspergillus¯avus conidia membranes contain ergosterol and cholesterol (DeLucca et al. 1997) which could be the target of bacillomycin D. Both the peptide cycle and the lipid chain are important for the activity of the lipopeptides. The present results indicated that the length of the b-amino acid may play a role in speci®city, leading to differential inhibitory effects against various fungal species. Further research is being conducted to investigate the mechanism of action of bacillomycin D and its analogues against A.¯avus. Biosynthesis of bacillomycin D is independent of the ribosomal process (Besson and Michel 1992) and the enzymes responsible for bacillomycin D production are complex peptide synthetases. Peptide synthetases are organized as modules which determine the order of the amino acid sequence in the lipopeptides. By recombining the different modules, it would be possible to modify bacillomycin D and create new antibiotics, as has already been shown for the surfactin (Stachelhaus et al. 1995) and the polyketide synthases (Gokhale et al. 1999 ). Thus, cloning the genes encoding the peptide synthetases will allow a better understanding of the relation between the activity and the structure of bacillomycin D, and perhaps create more potent antifungal peptides analogues. 
